Product Detail

Name: Enfuvirtide  

Feature: 

For human immunodeficiency virus (HIV) infection, combined with reverse transcriptase drugs.

This product is a synthetic peptide HIV fusion inhibitor, which can combine with viral envelope glycoprotein to prevent the conformational changes necessary for the fusion of virus and cell membrane, thus inhibiting the replication of HIV-1. Nfweipeptide is derived from a natural chemicalbook amino acid sequence in the HR2 domain of gp41. By simulating the activity of the HR2 domain and competing to bind to the HR1 domain of gp41, it prevents the interaction between HR1 and HR2 and changes in the configuration of gp41, thus preventing the fusion of the virus and the host cell.

Composition:

Assay: 99%

Appearance: White powder

CAS No. 159519-65-0

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.